<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 6-day-old female newborn, readmitted for extreme <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> with <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:hpo ids='HP_0001298'>encephalopathy</z:hpo>, died despite 2 double-volume exchange transfusions </plain></SENT>
<SENT sid="1" pm="."><plain>On autopsy examination the basal ganglia and hippocampus were selectively stained deep yellow </plain></SENT>
<SENT sid="2" pm="."><plain>The infant was heterozygous for both the <z:chebi fb="105" ids="17234">glucose</z:chebi>-6-phosphate dehydrogenase Mediterranean mutation and for the (TA)(6)/(TA)(7) promoter polymorphism for the gene encoding the <z:chebi fb="0" ids="16990">bilirubin</z:chebi> conjugating enzyme <z:chebi fb="0" ids="17659">uridine diphosphate</z:chebi>-glucuronosyltransferase 1A1 (UGT1A1*28, associated with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>No additional mutations of the UGT1A1 were detected </plain></SENT>
<SENT sid="4" pm="."><plain>Seemingly innocuous, heterozygotic mutations may interact synergistically to result in serious and even fatal outcomes </plain></SENT>
</text></document>